Middle East & Africa Anti-Infective Agents Market Size & Outlook
The anti-infective agents market in Middle East & Africa is expected to reach a projected revenue of US$ 4,862.9 million by 2033. A compound annual growth rate of 1.4% is expected of Middle East & Africa anti-infective agents market from 2026 to 2033.
The MEA anti-infective agents market generated a revenue of USD 4,474.9 million in 2025.
The market is expected to grow at a CAGR of 1.4% from 2026 to 2033.
In terms of segment, antivirals was the largest revenue generating type in 2025.
Antifungals is the most lucrative type segment registering the fastest growth during the forecast period.
Country-wise, South Africa is expected to register the highest CAGR from 2026 to 2033.
MEA data book summary
Market revenue in 2025
USD 4,474.9 million
Market revenue in 2033
USD 4,862.9 million
Growth rate
1.4% (CAGR from 2026 to 2033)
Largest segment
Antivirals
Fastest growing segment
Antifungals
Historical data covered
2021 - 2024
Base year for estimation
2025
Forecast period covered
2026 - 2033
Quantitative units
Revenue in USD million
Market segmentation
Antibacterials, Antivirals, Antifungals
Key market players worldwide
Pfizer Inc, Abbott Laboratories, Gilead Sciences Inc, Bristol-Myers Squibb Co, Merck & Co Inc, Sandoz Group AG ADR, B. Braun, Novo Holdings, Mankind Pharma, Bayer AG, AstraZeneca PLC, Boehringer Ingelheim Pharma
Other key industry trends
In terms of revenue, MEA region accounted for 3.3% of the global anti-infective agents market in 2025.
Globally, North America is projected to lead the regional market in terms of revenue in 2033.
Asia Pacific is the fastest growing regional market and is projected to reach USD 44,829.0 million by 2033.
The anti-infective agents market in the Middle East and Africa (MEA) is witnessing substantial growth, driven by an increasing prevalence of infectious diseases and heightened awareness of their impact on public health.
Conditions such as tuberculosis, malaria, HIV/AIDS, and various bacterial infections are widespread in parts of the region, underscoring the urgent need for effective treatment solutions. The Middle East and North Africa (MENA) region is one of only two areas globally where HIV cases are increasing.
Awareness campaigns, often supported by both government and non-governmental organizations, play a vital role in educating communities about infection prevention and encouraging the use of prescribed treatments.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Anti-infective Agents Market Outlook will help companies and investors design strategic landscapes.
Antivirals was the largest segment with a revenue share of 39.84% in 2025.
Horizon Databook has segmented the Middle East & Africa anti-infective agents market based on antibacterials, antivirals, antifungals covering the revenue growth of each sub-segment from 2021 to 2033.
The anti-infective agents market in the Middle East and Africa (MEA) is witnessing substantial growth, driven by an increasing prevalence of infectious diseases and heightened awareness of their impact on public health.
Conditions such as tuberculosis, malaria, HIV/AIDS, and various bacterial infections are widespread in parts of the region, underscoring the urgent need for effective treatment solutions. The Middle East and North Africa (MENA) region is one of only two areas globally where HIV cases are increasing.
Awareness campaigns, often supported by both government and non-governmental organizations, play a vital role in educating communities about infection prevention and encouraging the use of prescribed treatments.
Middle East & Africa Anti-Infective Agents Market Type Outlook (Revenue, USD Million , 2021-2033)
Antibacterials
Antivirals
Antifungals
Middle East & Africa Anti-Infective Agents Market Route of Administration Outlook (Revenue, USD Million , 2021-2033)
Oral
Parenteral
Topical
Others
Middle East & Africa Anti-Infective Agents Market Distribution Channel Outlook (Revenue, USD Million , 2021-2033)
Hospital Pharmacies
Retail Pharmacies
Others
Reasons to subscribe to anti infective agents market databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of anti infective agents market databook
Our clientele includes a mix of anti infective agents market companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa anti infective agents market, including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa anti infective agents market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Middle East Africa Anti-Infective Agents Market, 2021-2033 (US$M)